Epileptic Seizure Following A Switch From Short-acting Methylphenidate to Long-acting Methylphenidate Treatment: A Case Report
Methylphenidate is the most commonly prescribed psychostimulant medication for attention deficit hyperactivity disorder (ADHD). Its efficacy and tolerability in children and adults have been described in numerous studies. Side effects frequently reported during methylphenidate use include appetite l...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Turkish |
| Published: |
Galenos Yayinevi
2019-11-01
|
| Series: | Çocuk ve Gençlik Ruh Sağlığı Dergisi |
| Subjects: | |
| Online Access: |
http://cogepderg.com/archives/archive-detail/article-preview/epileptic-seizure-following-a-switch-from-short-ac/30746
|
| Summary: | Methylphenidate is the most commonly prescribed psychostimulant medication for attention deficit hyperactivity disorder (ADHD). Its efficacy and tolerability in children and adults have been described in numerous studies. Side effects frequently reported during methylphenidate use include appetite loss, irritability, restlessness, headache, insomnia, abdominal pain, and nausea. Methylphenidate is widely accepted to lower seizure threshold. However, both long-acting and short-acting methylphenidate are generally well tolerated with a similar side effect profile. Here we present a child with ADHD a history of seizure, who developed epileptic seizure following a switch from short-acting methylphenidate to long-acting methylphenidate treatment (Medikinet retard®) discussing with the literature findings. |
|---|---|
| ISSN: | 1301-3904 2687-3532 |